Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ebeling

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|October 1, 1993
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activityP Ebeling, R Bourey, L Koranyi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsM R Nowrousian, S Waschke, P Bojko, et al.
Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
The American Journal of Physiology|February 1, 1996
Postmarathon paradox: insulin resistance in the face of glycogen depletionJ A Tuominen, P Ebeling, R Bourey, et al.
Diabetologia|January 29, 2000
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetesP Ebeling, A M Teppo, H A Koistinen, et al.
Leukemia|August 26, 2006
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression statusA Hüttmann, L Klein-Hitpass, J Thomale, et al.
Diabetologia|December 24, 2004
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathyM Saraheimo, C Forsblom, T K Hansen, et al.
Neurology|February 1, 1996
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesisG A Suarez, C Giannini, E P Bosch, et al.
European Journal of Haematology|December 23, 2004
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaP Schütt, P Ebeling, U Buttkereit, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|October 1, 1993
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activityP Ebeling, R Bourey, L Koranyi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsM R Nowrousian, S Waschke, P Bojko, et al.
Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
The American Journal of Physiology|February 1, 1996
Postmarathon paradox: insulin resistance in the face of glycogen depletionJ A Tuominen, P Ebeling, R Bourey, et al.
Diabetologia|January 29, 2000
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetesP Ebeling, A M Teppo, H A Koistinen, et al.
Leukemia|August 26, 2006
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression statusA Hüttmann, L Klein-Hitpass, J Thomale, et al.
Diabetologia|December 24, 2004
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathyM Saraheimo, C Forsblom, T K Hansen, et al.
Neurology|February 1, 1996
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesisG A Suarez, C Giannini, E P Bosch, et al.
European Journal of Haematology|December 23, 2004
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaP Schütt, P Ebeling, U Buttkereit, et al.
Pageof 8